Home › Research › Biomarkers
Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers
Bouteloup V, Villain N, Vidal JS, Gonzalez-Ortiz F, Yuksekel I, Santos C, Schraen-Maschken S, Pellegrin I et al.. JAMA neurology, 2025-05-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
However, the importance of detailed cognitive phenotyping in patients without dementia when interpreting p-tau217 results remains unclear. Results A total of 776 participants from the MEMENTO cohort (N = 2323 participants) and 193 participants from the BALTAZAR cohort (N = 1040) were included in this analysis. Replicated analyses in the BALTAZAR cohort provided similar results. Conclusions and relevance Results from 2 clinical cohorts suggest that amyloid prevalence varied across cognitive phenotypes and was associated with the diagnostic performance of blood p-tau217 models to determine brain amyloidosis.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 2,323 participants. In two clinical cohorts, the prevalence of amyloid varied across cognitive phenotypes and this was associated with how well blood p-tau217 models detected brain amyloid. Reported effect size: 16.5%; 45.9%; 24.5%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bouteloup, V., Villain, N., Vidal, J. S., Gonzalez-Ortiz, F., Yuksekel, I., Santos, C., et al. (2025). Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers. JAMA neurology. https://doi.org/10.1001/jamaneurol.2025.0142
Vancouver
Bouteloup V, Villain N, Vidal JS, Gonzalez-Ortiz F, Yuksekel I, Santos C, et al. Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers. JAMA neurology. 2025. doi:10.1001/jamaneurol.2025.0142. PMID: 40181683.
BibTeX
@article{bouteloup2025-40181683,
author = {Bouteloup, V. and Villain, N. and Vidal, J. S. and Gonzalez-Ortiz, F. and Yuksekel, I. and Santos, C. and Schraen-Maschken, S. and Pellegrin, I. and others},
title = {{Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers}},
journal = {JAMA neurology},
year = {2025},
doi = {10.1001/jamaneurol.2025.0142},
pmid = {40181683},
url = {https://doi.org/10.1001/jamaneurol.2025.0142}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- However, the importance of detailed cognitive phenotyping in patients without dementia when interpreting p-tau217 results remains unclear.
- Results A total of 776 participants from the MEMENTO cohort (N = 2323 participants) and 193 participants from the BALTAZAR cohort (N = 1040) were included in this analysis.
- Replicated analyses in the BALTAZAR cohort provided similar results.
- Conclusions and relevance Results from 2 clinical cohorts suggest that amyloid prevalence varied across cognitive phenotypes and was associated with the diagnostic performance of blood p-tau217 models to determine brain amyloidosis.
Why it matters
In two clinical cohorts, the prevalence of amyloid varied across cognitive phenotypes and this was associated with how well blood p-tau217 models detected brain amyloid. This concerns how to interpret a blood test, not a treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcohort study
- Participants2,323
- Effect size16.5%; 45.9%; 24.5%
- Evidence strengthModerate
How this study scored 70/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA neurology) |
| Journal's citation record | 2 / 4 | JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,323 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 35 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 11.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 5 / 6 | Cited 22.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 2 / 4 | Cited 35 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Christine Delmaire: h-index 48 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Centre National de la Recherche Scientifique: institution h-index 2,511 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 20 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40181683) |
| Free to read | 2 / 2 | Free to read |
| Total | 70 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamaneurol.2025.0142
- PubMed: 40181683
- Original source →
- Free full text: JAMA Neurology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.